These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2656020)

  • 1. Nicardipine, a new calcium channel blocker: role for vascular selectivity.
    Pepine C
    Clin Cardiol; 1989 May; 12(5):240-6. PubMed ID: 2656020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP
    Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for angina pectoris: comparison of nicardipine with other antianginal agents.
    Scheidt S
    Am Heart J; 1988 Jul; 116(1 Pt 1):254-9. PubMed ID: 3293394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.
    Little WC; Cheng CP; Elvelin L; Nordlander M
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):657-63. PubMed ID: 8573548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of nicardipine for angina pectoris.
    Pepine CJ; Lambert CR
    Am J Cardiol; 1987 Jun; 59(17):13J-19J. PubMed ID: 3300237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium channel blockers in clinical medicine.
    Urthaler F
    Am J Med Sci; 1986 Oct; 292(4):217-30. PubMed ID: 2428245
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine.
    Sugiyama A; Satoh Y; Takahara A; Ando K; Nakamura Y; Hashimoto K
    Heart Vessels; 2005 May; 20(3):112-5. PubMed ID: 15912307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with nicardipine and beta-adrenergic blockade for angina pectoris.
    Lambert CR
    Clin Cardiol; 1992 Apr; 15(4):231-4. PubMed ID: 1348670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.
    Rousseau MF; Vincent MF; Cheron P; van den Berghe G; Charlier AA; Pouleur H
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):147S-157S. PubMed ID: 2862900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris.
    Hanet C; Rousseau MF; van Eyll C; Pouleur H
    Circulation; 1990 Feb; 81(2 Suppl):III148-54. PubMed ID: 2297879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.
    Gradman AH
    Can J Cardiol; 1995 Apr; 11 Suppl B():14B-21B. PubMed ID: 7728649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
    Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicardipine--a new calcium-entry blocker.
    Med Lett Drugs Ther; 1989 May; 31(791):41-2. PubMed ID: 2710026
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
    Rodrigues EA; Lahiri A; Raftery EB
    Eur Heart J; 1987 Jun; 8(6):624-9. PubMed ID: 3622543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure.
    Lahiri A; Rodrigues EA; Carboni GP; Raftery EB
    Circulation; 1990 Feb; 81(2 Suppl):III130-8. PubMed ID: 2404636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous nicardipine: a new calcium antagonist for perioperative use].
    Muñoz Alameda LE; Barcina Sánchez M
    Rev Esp Anestesiol Reanim; 2001 Feb; 48(2):71-80. PubMed ID: 11257955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.